Muromonab-CD3
-
Subject Areas on Research
- A prospective randomized trial of OKT3 vs ATGAM induction therapy in pancreas transplant recipients.
- Activated T lymphocytes regulate hyaluronan binding to monocyte CD44 via production of IL-2 and IFN-gamma.
- CD2-mediated IL-12-dependent signals render human gamma delta-T cells resistant to mitogen-induced apoptosis, permitting the large-scale ex vivo expansion of functionally distinct lymphocytes: implications for the development of adoptive immunotherapy strategies.
- Case study: heart transplantation--increased incidence of acute rejection in female recipients.
- Comparison of Minnesota antilymphoblast globulin and Upjohn antithymocyte globulin for induction immunosuppression of human renal allografts.
- Comparison of thymocyte development and cytokine production in CD7-deficient, CD28-deficient and CD7/CD28 double-deficient mice.
- Experience with 500 simultaneous pancreas-kidney transplants.
- HLA class II molecules on monocytes regulate T cell proliferation through physical interaction in the CD3 activation pathway.
- Impact of improving immunosuppressive treatment on outcome in cadaveric kidney transplantation.
- Increased risk of pulmonary edema in diabetic patients undergoing preemptive pancreas transplantation with OKT3 induction.
- Induction immunosuppression.
- Long-term outcomes in simultaneous kidney-pancreas transplant recipients.
- OKT3 vs ALG induction therapy in combined pancreas-kidney transplantation.
- Radiation therapy for renal transplant rejection refractory to pulse steroids and OKT3.
- Should abdominal cluster transplantation be abandoned?
- The B7-2 (B70) costimulatory molecule expressed by monocytes and activated B lymphocytes is the CD86 differentiation antigen.
- The clinical application of monoclonal antibody therapies in renal transplantation.
- Unidirectional, heterologous desensitization of the pertussis toxin receptor by the CD3/TCR complex.
- Use of OKT3 in kidney, pancreas, and liver transplantation.